A Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Genetic Obesity

Clinical trial NCT06041841 · UNKNOWN

Trial details

NCT number: NCT06041841
Sponsor: LG Chem
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

POMC Deficiency Obesity PCSK1 Deficiency Obesity LEPR Deficiency Obesity

Start date: 2023-12-01
Primary completion: 2024-12-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.